Glucagon regulates lipolysis and fatty acid oxidation through inositol triphosphate receptor 1 in the liver.

Glucagon promotes hepatic glucose production, lipolysis and amino acid catabolism. Inhibition of glucagon activity, or glucagon resistance, not only lowers blood glucose levels, but also induces non-alcoholic fatty liver disease and hyperaminoacidemia.